RxNorm Semantic Concepts Index - 402
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "402".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402000 | ZOLMitriptan 5 MG/ACTUAT Nasal Spray | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402006 | cimetidine 200 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402006 | cimetidine 200 MG per 5 ML Oral Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402006 | cimetidine 200 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402006 | cimetidine 200 MG per 5 ML Oral Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402008 | efavirenz 30 MG/ML Oral Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402008 | efavirenz 30 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402008 | efavirenz 30 MG/ML Oral Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402010 | risperiDONE 25 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402011 | risperiDONE 37.5 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402012 | risperiDONE 50 MG Extended Release Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402013 | omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402014 | omeprazole 20 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402015 | omeprazole 40 MG Delayed Release Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402019 | tadalafil 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402019 | tadalafil 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402019 | tadalafil 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402019 | tadalafil 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402022 | witch hazel 13 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402022 | witch hazel 13 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402022 | witch hazel 13 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402023 | calcium phosphate 3100 MG / cholecalciferol 0.02 MG Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402058 | BCG, Connaught strain 81 MG for Intravesical Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402058 | BCG, Connaught strain 81 MG for Intravesical Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402058 | BCG, Connaught strain 81 MG for Intravesical Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40207 | Lymphocyte antigen CD115 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 40207 | Lymphocyte antigen CD115 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402071 | GT1b immunoglobulin G ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402071 | GT1b immunoglobulin G ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402071 | GT1b immunoglobulin G ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402072 | GQ1b immunoglobulin G ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402072 | GQ1b immunoglobulin G ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402072 | GQ1b immunoglobulin G ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402073 | GQ1b immunoglobulin M ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402073 | GQ1b immunoglobulin M ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402073 | GQ1b immunoglobulin M ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402074 | GT1b immunoglobulin M ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402074 | GT1b immunoglobulin M ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402074 | GT1b immunoglobulin M ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402075 | GM1 immunoglobulin G ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402075 | GM1 immunoglobulin G ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402075 | GM1 immunoglobulin G ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402076 | GM1 immunoglobulin M ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402076 | GM1 immunoglobulin M ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402076 | GM1 immunoglobulin M ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402077 | GD1a immunoglobulin M ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402077 | GD1a immunoglobulin M ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402077 | GD1a immunoglobulin M ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402078 | GD1a immunoglobulin G ganglioside antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402078 | GD1a immunoglobulin G ganglioside antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402078 | GD1a immunoglobulin G ganglioside antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402079 | Caspase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402079 | Caspase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402080 | Immunoglobulin G caspase antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402080 | Immunoglobulin G caspase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402080 | Immunoglobulin G caspase antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402085 | Factive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 402089 | gatifloxacin 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402089 | gatifloxacin 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402089 | gatifloxacin 0.3 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402089 | gatifloxacin 0.3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402089 | gatifloxacin 0.3 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402090 | Zymar 0.3 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402090 | Zymar 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402090 | Zymar 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402090 | Zymar 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402091 | Iressa 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402091 | Iressa 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402091 | Iressa 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402092 | Restasis 0.05 % Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402093 | Reyataz 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402093 | Reyataz 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402093 | Reyataz 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402094 | Reyataz 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402094 | Reyataz 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402094 | Reyataz 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402095 | Reyataz 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402095 | Reyataz 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402095 | Reyataz 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402096 | Cialis 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402096 | Cialis 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402096 | Cialis 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402097 | Cialis 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402097 | Cialis 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402097 | Cialis 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402099 | Climara Pro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4021 | Ergometrine-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402100 | abarelix 50 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402101 | abarelix 50 MG/ML Injectable Suspension [Plenaxis] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402101 | abarelix 50 MG/ML Injectable Suspension [Plenaxis] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402103 | Antigen of Plasmodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402103 | Antigen of Plasmodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402103 | Antigen of Plasmodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402103 | Antigen of Plasmodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402103 | Antigen of Plasmodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402104 | Raptiva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 402105 | INSPRA 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402105 | INSPRA 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402105 | INSPRA 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402106 | INSPRA 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402106 | INSPRA 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402106 | INSPRA 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402107 | INSPRA 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402107 | INSPRA 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402107 | INSPRA 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402108 | Lexiva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 402109 | fosamprenavir calcium 700 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402109 | fosamprenavir calcium 700 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402109 | fosamprenavir calcium 700 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402109 | fosamprenavir calcium 700 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402109 | fosamprenavir calcium 700 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402110 | Lexiva 700 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402110 | Lexiva 700 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402110 | Lexiva 700 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402110 | Lexiva 700 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402121 | Papaya and/or papaya derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402121 | Papaya and/or papaya derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402122 | Benzothiazepine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402122 | Benzothiazepine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402123 | Diarylaminopropylamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402123 | Diarylaminopropylamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402125 | Nonsteroidal antiandrogen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402125 | Nonsteroidal antiandrogen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402131 | ARIPiprazole 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402131 | ARIPiprazole 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402131 | ARIPiprazole 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402131 | ARIPiprazole 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402131 | ARIPiprazole 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402140 | Estrasorb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 402153 | Entire pollen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402153 | Entire pollen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402154 | Pollen part | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402154 | Pollen part | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402156 | Complement component C1q antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402156 | Complement component C1q antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402157 | Monomeric prolactin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402157 | Monomeric prolactin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402158 | Anti-cyclic citrullinated peptide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402158 | Anti-cyclic citrullinated peptide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402159 | Liver antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402159 | Liver antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402168 | Substance with cyclic lipopeptide structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402168 | Substance with cyclic lipopeptide structure and antibacterial mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402168 | Substance with cyclic lipopeptide structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402168 | Substance with cyclic lipopeptide structure and antibacterial mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402168 | Substance with cyclic lipopeptide structure and antibacterial mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402169 | Zomig 5 MG/ACTUAT Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402169 | Zomig 5 MG/ACTUAT Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402169 | Zomig 5 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402169 | Zomig 5 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402190 | Nuclear phosphoprotein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402190 | Nuclear phosphoprotein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402197 | Directed donor blood product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402197 | Directed donor blood product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402198 | Directed donor packed red cells | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402198 | Directed donor packed red cells | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402199 | Directed donor whole blood | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402199 | Directed donor whole blood | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 4022 | Ergosterol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4022 | Ergosterol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 4022 | Ergosterol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4022 | Ergosterol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402236 | Hemoglobin O | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 402236 | Hemoglobin O | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402236 | Hemoglobin O | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402239 | efalizumab 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 40224 | CD15 - Cluster of differentiation antigen 15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402240 | efalizumab 100 MG/ML Injectable Solution [Raptiva] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402240 | efalizumab 100 MG/ML Injectable Solution [Raptiva] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402242 | estradiol 0.05 MG/24HR Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402242 | estradiol 0.05 MG/24HR Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402243 | bortezomib 3.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402243 | bortezomib 3.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402243 | bortezomib 3.5 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402243 | bortezomib 3.5 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402244 | VELCADE 3.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402244 | VELCADE 3.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402244 | VELCADE 3.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402245 | atazanavir sulfate 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402245 | atazanavir sulfate 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402245 | atazanavir sulfate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402245 | atazanavir sulfate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402245 | atazanavir sulfate 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402246 | atazanavir sulfate 150 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402246 | atazanavir sulfate 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402246 | atazanavir sulfate 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402246 | atazanavir sulfate 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402246 | atazanavir sulfate 150 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402247 | atazanavir sulfate 200 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402247 | atazanavir sulfate 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402247 | atazanavir sulfate 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402247 | atazanavir sulfate 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402247 | atazanavir sulfate 200 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402248 | desirudin 15 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402248 | desirudin 15 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402249 | Iprivask 15 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402249 | Iprivask 15 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402249 | Iprivask 15 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402250 | estradiol 0.045 MG / levonorgestrel 0.015 MG/Day Weekly Transdermal System | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402252 | Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402252 | Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402252 | Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402252 | Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 40227 | Technetium (99m-Tc) pentetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 40227 | Technetium (99m-Tc) pentetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402273 | vardenafil HCl 2.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402273 | vardenafil HCl 2.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402273 | vardenafil HCl 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402273 | vardenafil HCl 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402273 | vardenafil HCl 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402274 | Product containing amylase and pancrelipase and triacylglycerol lipase (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402274 | Product containing amylase and pancrelipase and triacylglycerol lipase (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402287 | Product containing psyllium and senna (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402287 | Product containing psyllium and senna (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402288 | Product containing Frangula and Sterculia gum (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402288 | Product containing Frangula and Sterculia gum (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402290 | Gliadin antibody, immunoglobulin A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402290 | Gliadin antibody, immunoglobulin A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402290 | Gliadin antibody, immunoglobulin A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402291 | Gliadin antibody, immunoglobulin G | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402291 | Gliadin antibody, immunoglobulin G | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402291 | Gliadin antibody, immunoglobulin G | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402292 | Gliadin antibody, immunoglobulin M | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402292 | Gliadin antibody, immunoglobulin M | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402292 | Gliadin antibody, immunoglobulin M | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402293 | Platelet associated immunoglobulin M | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402293 | Platelet associated immunoglobulin M | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402299 | U3 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402299 | U3 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402299 | U3 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 4023 | Ergot alkaloid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4023 | Ergot alkaloid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 4023 | Ergot alkaloid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4023 | Ergot alkaloid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 4023 | Ergot alkaloid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 40230 | thymopentin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402300 | U4 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402300 | U4 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402300 | U4 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402301 | U6 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402301 | U6 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402301 | U6 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402305 | U7 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402305 | U7 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402305 | U7 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402307 | U1 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402307 | U1 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402307 | U1 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402308 | U2 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402308 | U2 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402308 | U2 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402309 | U5 snRNP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402309 | U5 snRNP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402309 | U5 snRNP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402316 | Miglustat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 402316 | Miglustat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402316 | Miglustat | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402316 | Miglustat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402316 | Miglustat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402316 | Miglustat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402322 | epinastine Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402323 | Elestat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 402324 | epinastine Ophthalmic Solution [Elestat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402330 | cycloSPORINE Ophthalmic Suspension [Restasis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402330 | cycloSPORINE Ophthalmic Suspension [Restasis] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402332 | atazanavir 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402333 | atazanavir Oral Capsule [Reyataz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402334 | atazanavir 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402335 | atazanavir 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402336 | witch hazel 130 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402337 | witch hazel Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402338 | abarelix 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402339 | abarelix Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402340 | abarelix Injectable Suspension [Plenaxis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402341 | oxyCODONE Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402341 | oxyCODONE Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402343 | levocetirizine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402346 | miglustat 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402346 | miglustat 100 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402347 | miglustat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402347 | miglustat Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402348 | risperiDONE Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402348 | risperiDONE Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402349 | levocetirizine dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 402349 | levocetirizine dihydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402349 | levocetirizine dihydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402350 | efalizumab 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402351 | efalizumab Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402352 | meclizine Oral Lozenge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402354 | rosuvastatin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402357 | desloratadine 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402359 | temoporfin 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402360 | temoporfin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402363 | eplerenone Oral Tablet [Inspra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402364 | fosamprenavir 700 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402365 | Fosamprenavir calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 402365 | Fosamprenavir calcium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402365 | Fosamprenavir calcium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402366 | fosamprenavir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402367 | fosamprenavir Oral Tablet [Lexiva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402368 | aripiprazole 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402368 | aripiprazole 5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402369 | efalizumab Injectable Solution [Raptiva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402370 | atazanavir Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402375 | estradiol 0.00188 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402376 | levonorgestrel 0.000625 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402379 | estradiol Topical Lotion [Estrasorb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402381 | vardenafil 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402382 | estradiol Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402383 | procyclidine Injectable Solution [Kemadrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402384 | oxygen 99.1 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402385 | dolasetron 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402390 | lutropin alfa Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402391 | zolmitriptan 5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402391 | zolmitriptan 5 MG/ACTUAT | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402392 | zolmitriptan Nasal Spray [Zomig] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402392 | zolmitriptan Nasal Spray [Zomig] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402398 | evening primrose oil 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402399 | evening primrose oil Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 4024 | Dihydroergotoxine mesilate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402400 | valdecoxib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402401 | methyl 5-aminolevulinate 160 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402402 | methyl 5-aminolevulinate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402407 | olmesartan medoxomil 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402408 | nabilone 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402409 | nabilone 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402410 | nabilone 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402411 | traMADol Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402411 | traMADol Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402412 | SUMAtriptan 10 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402412 | SUMAtriptan 10 MG/ACTUAT | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402419 | promazine Oral Suspension [Sparine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402420 | zolmitriptan Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402420 | zolmitriptan Nasal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402421 | vancomycin Oral Capsule [Vancocin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402422 | efavirenz 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402423 | efavirenz Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402424 | omeprazole Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402425 | calcium phosphate 3100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402426 | cholecalciferol 0.02 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402427 | calcium phosphate / cholecalciferol Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402429 | Gemifloxacin mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402429 | Gemifloxacin mesilate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402429 | Gemifloxacin mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 402429 | Gemifloxacin mesilate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402430 | gemifloxacin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402431 | gemifloxacin Oral Tablet [Factive] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402432 | gatifloxacin 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402433 | gatifloxacin Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402434 | gatifloxacin Ophthalmic Solution [Zymar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402435 | gefitinib Oral Tablet [Iressa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402436 | tadalafil 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402437 | tadalafil Oral Tablet [Cialis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402438 | tadalafil 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402440 | Glycosylated albumin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402440 | Glycosylated albumin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402443 | immunoglobulin G Injectable Solution [Kabiglobulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402444 | immunoglobulin G Injectable Solution [Gammabulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402447 | diflucortolone Topical Cream [Nerisone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402449 | vitamin B6 Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402450 | Actinomycetes species antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402450 | Actinomycetes species antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402452 | tadalafil Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402455 | diphtheria toxoid vaccine, inactivated 4 LFU/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402456 | tetanus toxoid vaccine, inactivated 10 LFU/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402457 | diphtheria toxoid vaccine, inactivated 25 LFU/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402458 | mumps skin test antigen 40 CFU/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402465 | hexachlorophene 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402466 | chlorhexidine / chlorobutanol Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402467 | chlortetracycline 115 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402469 | tetracycline 115 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402470 | chlortetracycline / demeclocycline / tetracycline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402471 | noxythiolin 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402472 | noxythiolin Irrigation Solution [Noxyflex-S] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402473 | anthraquinone glycoside 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402477 | sodium bicarbonate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402480 | anthraquinone glycoside / salicylic acid Mucous Membrane Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402481 | isopropyl alcohol 99 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402481 | isopropyl alcohol 99 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402481 | isopropyl alcohol 99 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402496 | Paste | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 402499 | Chewing Gum | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 4025 | Ergotamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 4025 | Ergotamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4025 | Ergotamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 4025 | Ergotamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4025 | Ergotamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402505 | carBAMazepine 200 MG 12HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402506 | carBAMazepine 400 MG 12HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402514 | Methaqualone hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402514 | Methaqualone hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402519 | levopropoxyphene napsylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 402520 | Tuaminoheptane sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402520 | Tuaminoheptane sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402520 | Tuaminoheptane sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402527 | chlorphenindione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402538 | ethoxazene hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 40254 | Valproate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 40254 | Valproate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 40254 | Valproate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402565 | Dibunate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402565 | Dibunate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402565 | Dibunate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402565 | Dibunate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402565 | Dibunate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402567 | eprozinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 402579 | brovanexine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 402580 | azintamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402583 | clocinizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402584 | clocinizine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 402587 | difetarsone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 402588 | difetarsone sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 402597 | calcium acetate 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 402597 | calcium acetate 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402601 | protease 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402602 | protease 30000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402603 | propylene glycol 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402605 | propylene glycol 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402606 | propylene glycol 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402610 | propylene glycol 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402611 | propylene glycol 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402621 | aluminum chlorohydrate 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402622 | policresulen 0.018 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402625 | sulfamethoxazole 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402626 | trimethoprim 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402627 | protease 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402628 | protease 25000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402629 | protease 20000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402630 | protease 24000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402631 | protease 48000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402633 | protease 44000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402634 | protease 39000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402635 | protease 65000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402636 | protease 18800 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402637 | protease 37500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402638 | protease 75000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402639 | protease 59000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402640 | protease 45000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402641 | protease 60000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402642 | protease 15000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402646 | protease 19000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402647 | protease 70000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402648 | protease 12500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402649 | protease 19500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402650 | protease 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402651 | protease 13000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402652 | protease 50000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402653 | protease 32000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402654 | protease 63000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402655 | protease 78000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402656 | protease 97500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402657 | turpentine 0.045 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402659 | magnesium malate 108 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402660 | protease 38000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402661 | protease 55000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402662 | protease 12000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402665 | soy protein isolate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402666 | soy protein isolate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402667 | propylene glycol 0.2 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402669 | follitropin alfa 37.5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402671 | herpesvirus 3, human 2700 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402672 | levorotatory alkaloids of belladonna 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402673 | levorotatory alkaloids of belladonna 0.12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402674 | BCG, live, Connaught strain 27 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402675 | levorotatory alkaloids of belladonna 0.125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402676 | follitropin alfa 300 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402677 | cefotaxime 1000 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 402681 | ketoconazole 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402686 | protease 6000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402687 | protease 3000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402688 | protease 58500 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402689 | erythromycin 0.85 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402690 | soy protein isolate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402691 | soy protein isolate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402692 | soy protein isolate 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402693 | follitropin alfa 600 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402695 | felodipine 10 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402695 | felodipine 10 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402695 | felodipine 10 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402695 | felodipine 10 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402695 | felodipine 10 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402696 | felodipine 5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402696 | felodipine 5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402696 | felodipine 5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402696 | felodipine 5 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402696 | felodipine 5 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402698 | felodipine 2.5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 402698 | felodipine 2.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 402698 | felodipine 2.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 402698 | felodipine 2.5 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 402698 | felodipine 2.5 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 402699 | propylene glycol 9.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402701 | soy protein isolate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402702 | soy protein isolate 55 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402704 | lactate Topical Cream [Lac-Hydrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402705 | lactate Topical Cream [Amlactin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402707 | treprostinil Injectable Solution [Remodulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402708 | muromonab-CD3 Injectable Solution [Orthoclone OKT3] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402712 | hydrocortisone / neomycin / polymyxin B Otic Solution [Otic care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402714 | lactate Topical Lotion [Laclotion] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402716 | lactate Topical Lotion [Lac-Hydrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402717 | lactate Topical Lotion [Amlactin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402718 | benzocaine / chloroxylenol Topical Ointment [Foille] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402725 | aluminum chlorohydrate / neomycin Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402729 | glycerin / propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402731 | glycerin / hypromellose / propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402733 | magnesium malate / malic acid / vitamin B6 Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402737 | propylene glycol Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402738 | camphor / Eucalyptus oil / menthol / turpentine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402740 | polyethylene glycols / propylene glycol Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402741 | follitropin alfa Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402745 | polyethylene glycols / propylene glycol Nasal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402747 | aluminum chlorohydrate / neomycin Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402748 | ergotamine / levorotatory alkaloids of belladonna / phenobarbital Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402748 | ergotamine / levorotatory alkaloids of belladonna / phenobarbital Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402749 | amylase / lipase / protease Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402751 | amylase / lipase / protease Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402754 | amylase / lipase / protease Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402786 | policresulen Vaginal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402787 | policresulen Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402791 | betaine / protease Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402811 | amylase / lipase / protease Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402812 | amylase / lipase / protease Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402813 | amylase / lipase / pancreatin / protease Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402814 | amylase / protease Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402817 | soy protein isolate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402820 | propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402822 | soy protein isolate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 402823 | policresulen 18 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402824 | cascara sagrada 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402825 | protease 600 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402826 | protease 3750 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402827 | protease 180000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402828 | varicella-zoster immune globulin 62.5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402830 | BCG, live, Montreal strain Irrigation Solution [Pacis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402832 | coal tar / salicylic acid / sulfur, colloidal Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402833 | BCG, live, Tice strain Irrigation Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402834 | sodium perborate Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402835 | chlortetracycline Topical Cream [Aureomycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402836 | chlortetracycline Topical Ointment [Aureomycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402838 | activated charcoal 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402839 | activated charcoal 140 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402840 | simethicone 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402841 | activated charcoal / simethicone Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402844 | Rho(D) immune globulin Injectable Solution [Partobulin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402845 | dydrogesterone Oral Tablet [Duphaston] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402864 | Drug eluding stent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402864 | Drug eluding stent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 402864 | Drug eluding stent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 402899 | tocopherol,DL-alpha | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 402907 | carbamazepine Rectal Suppository [Tegretol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402907 | carbamazepine Rectal Suppository [Tegretol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402908 | carBAMazepine Extended Release Oral Tablet [Teril CR] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402908 | carBAMazepine Extended Release Oral Tablet [Teril CR] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402909 | carBAMazepine Extended Release Oral Tablet [Timonil Retard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402909 | carBAMazepine Extended Release Oral Tablet [Timonil Retard] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402910 | carbamazepine 100 MG Oral Tablet [Tegretol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402910 | carbamazepine 100 MG Oral Tablet [Tegretol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402910 | carbamazepine 100 MG Oral Tablet [Tegretol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 402912 | piroxicam Oral Tablet [Brexidol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402913 | piroxicam Oral Tablet [Feldene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402914 | diphtheria toxoid vaccine, inactivated 20 LFU/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402915 | BCG, live, Montreal strain 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402916 | BCG, live, Montreal strain Irrigation Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402917 | ketoconazole 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402918 | ketoconazole Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402919 | ketoconazole Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 402920 | BCG, live, Tice strain 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 402921 | BCG, live, Tice strain 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 402925 | Tenoret | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 402926 | atenolol / chlorthalidone Oral Tablet [Tenoret] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402927 | atenolol / chlorthalidone Oral Tablet [Tenchlor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402928 | atenolol / chlorthalidone Oral Tablet [Totaretic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402929 | atenolol / chlorthalidone Oral Tablet [AtenixCo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402938 | testosterone Oral Capsule [Restandol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402939 | bumetanide Oral Solution [Burinex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402940 | bumetanide Injectable Solution [Burinex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402943 | Starlix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 402944 | nateglinide Oral Tablet [Starlix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402945 | ketoconazole Oral Suspension [Nizoral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402946 | ketoconazole Medicated Shampoo [Nizoral] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 402947 | testosterone Injectable Solution [Primoteston Depot] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402948 | labetalol Oral Tablet [Labrocol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402950 | hydrOXYzine Oral Tablet [Ucerax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402950 | hydrOXYzine Oral Tablet [Ucerax] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402952 | bisoprolol Oral Tablet [Emcor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402953 | bisoprolol Oral Tablet [Emcor LS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402954 | bisoprolol Oral Tablet [Monocor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402957 | Metenix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 402958 | metolazone Oral Tablet [Metenix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402958 | metolazone Oral Tablet [Metenix] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 402959 | repaglinide Oral Tablet [NovoNorm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402964 | sulfamethoxazole / trimethoprim Oral Tablet [Fectrim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402966 | sulfamethoxazole / trimethoprim Oral Tablet [Septrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402969 | sulfamethoxazole / trimethoprim Injectable Solution [Septrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402970 | sulfamethoxazole / trimethoprim Oral Tablet [Laratrim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402973 | Comox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 402974 | sulfamethoxazole / trimethoprim Oral Tablet [Comox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402975 | sulfamethoxazole / trimethoprim Oral Suspension [Comox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402976 | sulfamethoxazole / trimethoprim Oral Tablet [Comixco] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 402977 | clorazepate Oral Capsule [Tranxene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |